Table 4.
Mean healthcare cost per exacerbation in the 30 days after an exacerbation (US database only)
| Total all-cause ($) | Total asthma-related ($) | ||
|---|---|---|---|
| mean (SD) | mean (SD) | ||
| Overall | 1,368 (3,797) | 520 (981) | |
| GINA Step | Step 1 | 1,265 (3,981) | 446 (908) |
| Step 2 | 1,376 (3,978) | 465 (874) | |
| Step 3 | 1,253 (3,242) | 433 (782) | |
| Step 4 | 1,425 (3,817) | 516 (828) | |
| Step 5 | 1,814 (3,614) | 902 (1,533) | |
| Not classifiable/none | 946 (1,628) | 332 (377) | |
| Exacerbations during the 12-month pre-index period | <2 | 1,344 (3,836) | 477 (861) |
| ≥2 | 1,534 (3,516) | 754 (1,451) | |
| Severe uncontrolled asthmaa | Yes | 1,692 (3,233) | 911 (1,563) |
| No | 1,347 (3,831) | 486 (905) | |
| Severe uncontrolled eosinophilic asthmab | Yes | 2,040 (3,285) | 1,073 (1,958) |
| No | 1,692 (3,934) | 615 (1,248) |
aDefined as patients at GINA Step 4 or 5 with ≥2 exacerbations in the previous 12 months; bpatients with severe uncontrolled asthma criteria and blood eosinophil counts ≥300 cells/μl at baseline
GINA Global Initiative for Asthma, SD standard deviation